Maze Therapeutics, Inc. (MAZE)

CIK 1842295 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Maze Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 202640002050172-26-000036
Sep 4, 20261440001950047-26-009147
Sep 4, 202640001782758-26-000008
Sep 4, 202640001676170-26-000022
Sep 4, 202640002050172-26-000034
Sep 4, 202640002050167-26-000027
Sep 3, 202640002050167-26-000025
Sep 3, 202640001676170-26-000020
Sep 3, 202640001782758-26-000006
Sep 3, 202640002050172-26-000032
Sep 2, 20261440001782758-26-000005
Sep 2, 20261440002050167-26-000024
Sep 2, 20261440001676170-26-000019
Sep 2, 20261440002050172-26-000031
Sep 1, 20261440001969223-26-000973
Aug 31, 202640002050167-26-000023
Aug 17, 202640001341161-26-000005
Aug 17, 202630001894117-26-000005
Aug 17, 20268-K0001193125-26-354092
Aug 17, 202630001341161-26-000003
Aug 17, 202640001894117-26-000006
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097205
Aug 14, 202640002050172-26-000028
Aug 11, 20268-K0001193125-26-344878
Aug 11, 202610-Q0001193125-26-344903